BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Amylum {Starch} - Bifidobacterium pseudolongum |
👶
In vitro utilization of amylopectin and high-amylose maize (Amylomaize) starch granules by human colonic bacteria. Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 65 Issue 11 Pages: 4848-54 Pub: 1999 Nov Epub: Authors Wang X , Conway PL , Brown IL , Evans AJ , Html Article Publication |
| Amylum {Starch} - Bifidobacterium pseudolongum |
👶
Resistant Starch is Actively Fermented by Infant Faecal Microbiota and Increases Microbial Diversity. Nutrients (Nutrients ) Vol: 11 Issue 6 Pages: Pub: 2019 Jun 14 Epub: 2019 Jun 14 Authors Gopalsamy G , Mortimer E , Greenfield P , Bird AR , Young GP , Christophersen CT , Html Article Publication |
| Amylum {Starch} - Bifidobacterium pseudolongum |
👶
Safety and effects of acetylated and butyrylated high amylose maize starch in recently diagnosed youths with type 1 diabetes; a Pilot Study. medRxiv : the preprint server for health sciences (medRxiv ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Ismail HM , Liu J , Netherland M Jr , Evans-Molina C , DiMeglio LA , Html Article Publication |
| Amylum {Starch} - Bifidobacterium pseudolongum |
📓
Gut microbiota-directed intervention with high-amylose maize ameliorates metabolic dysfunction in diet-induced obese mice. Food & function (Food Funct ) Vol: 13 Issue 18 Pages: 9481-9495 Pub: 2022 Sep 22 Epub: 2022 Sep 22 Authors Chiou WC , Lai WH , Cai YL , Du ML , Lai HM , Chen JC , Huang HC , Liu HK , Huang C , Publication |
| Amylum {Starch} - Bifidobacterium pseudolongum |
👶
Starch acylation of different short-chain fatty acids and its corresponding influence on gut microbiome and diabetic indexes. Food chemistry (Food Chem ) Vol: 389 Issue Pages: 133089 Pub: 2022 Sep 30 Epub: 2022 Apr 26 Authors Li M , Wang F , Wang J , Wang A , Yao X , Strappe P , Zhou Z , Wu Q , Guo T , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
